Pub. Date : 2006 Jun
PMID : 16504219
7 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | L-3,4-dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic L-amino acid decarboxylase. | Levodopa | dopa decarboxylase | Rattus norvegicus |
2 | To map the DOPAergic system functionally, DOPA-induced c-Fos expression was detected under inhibition of central aromatic L-amino acid decarboxylase (AADC). | Levodopa | dopa decarboxylase | Rattus norvegicus |
3 | To map the DOPAergic system functionally, DOPA-induced c-Fos expression was detected under inhibition of central aromatic L-amino acid decarboxylase (AADC). | Levodopa | dopa decarboxylase | Rattus norvegicus |
4 | In rats treated with a central AADC inhibitor, DOPA significantly increased the number of c-Fos-positive nuclei in the paraventricular nuclei (PVN) and the nucleus tractus solitarii (NTS), and showed a tendency to increase in the supraoptic nuclei (SON), but not in the striatum. | Levodopa | dopa decarboxylase | Rattus norvegicus |
5 | On the other hand, DOPA with a peripheral AADC inhibitor elevated the level of c-Fos-positive nuclei in the four regions, suggesting that DOPA itself induces c-Fos expression in the SON, PVN and NTS. | Levodopa | dopa decarboxylase | Rattus norvegicus |
6 | On the other hand, DOPA with a peripheral AADC inhibitor elevated the level of c-Fos-positive nuclei in the four regions, suggesting that DOPA itself induces c-Fos expression in the SON, PVN and NTS. | Levodopa | dopa decarboxylase | Rattus norvegicus |
7 | In rats treated with 6-hydroxydopamine (6-OHDA) to lesion the nigrostriatal dopamine (DA) pathway, DOPA significantly induced c-Fos expression in the four regions under the inhibition of peripheral AADC. | Levodopa | dopa decarboxylase | Rattus norvegicus |